Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.

Trisha Suppes,Suresh Durgam,Susan G Kozauer,Richard Chen,Hassan D Lakkis,Robert E Davis,Andrew Satlin,Kimberly E Vanover,Sharon Mates,Roger S McIntyre,Mauricio Tohen

BIPOLAR DISORDERS（2023）

引用 3|浏览7

暂无评分

摘要

Lumateperone 42-mg treatment adjunctive to lithium or valproate significantly improved depression symptoms and was generally well tolerated in patients with MDEs associated with either bipolar I or bipolar II disorder.

查看译文

关键词

antipsychotic agent,bipolar depression,bipolar disorder,lumateperone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要